Kevin O'Leary, Martin Cech
Health Tech Nerds Radio
Where we share our weekly news debriefs and discussions with industry experts. These are lo-fi recordings aimed at giving our readers more opportunities to engage with our analysis and a view into some of the conversations that shape it.
Be sure to visit the podcast's website and support the creator: www.healthtechnerds.com
Author
Kevin O'Leary, Martin Cech
Category
Podcast website
Latest episode
Nov 17, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
The Grand Roundup: Oura’s $625M Counsel Health bet, Hims’ Q3 miss, Huberman’s $10M payday, Ro’s refounding story, CMS work requirements delay, and more 17.11.2026 1:03:19
With Rae out at HLTH, it’s just Kevin and Martin this week, and it’s a very consumer-heavy episode. They start with Oura’s $625M all-cash acquisition of Counsel Health, weeks after Oura pulled its IPO. Kevin argues the roadshow already told us Oura sees itself as a healthcare company, not a hardware maker, and that its real edge is a customer base that skews female and wealthy. From there it’s Him...
The Grand Roundup: Devoted’s commercial push, 2027 physician fee schedule, RPM reprieve, athenahealth Thrive Summit, employer GLP-1 pullback, and more 10.11.2026 1:02:37
Rae Woods officially joins Kevin and Martin at the table this week, and since the CVS and midterm news got its own emergency pod, the crew starts with Devoted. Job postings and comments from investor Annie Lamont suggest the high-flying MA plan is coming for large-group ASO. Kevin walks through the vertical-integration math behind the $100-to-$90 pitch. Then he explains why he thinks the leap prob...
The Grand Roundup: Q3 earnings from Centene to Lilly, HCA’s ACA-to-uninsured problem, Walmart and AI agents, Alignment’s miss, Medicaid frailty ruling, and more 03.11.2026 1:03:33
Kevin and Martin dig into a busy Q3 earnings week where payers keep winning and providers keep absorbing the affordability squeeze. Centene beat and raised, hit MA breakeven a year early, and barely mentioned ICHRA. Alignment stumbled on a claims platform migration, high-cost cases and a Stars drop in its core California plan. On the hospital side, more of HCA’s ACA members went uninsured than it...
The Grand Roundup: Molina’s rate vs. trend math, Elevance’s ASO IDR squeeze, reinventing insurance from scratch, the Bon Secours deal, and more 27.10.2026 1:13:45
Kevin and Martin open with the surprise news that Bon Secours is buying Surgery Partners, plus the Advocate headache of patients linking MyChart to ChatGPT, which sent Epic API calls up 7,000% and left Advocate paying for them. Then it’s Q3 payer earnings. Elevance beat, but mostly on investment gains, and says IDR costs are landing on its ASO book, which means employers are paying them. Molina’s...
The Grand Roundup: Q3 earnings special — the C-SNP land grab, Nebraska’s Medicaid warning sign, the big three PBMs hold, AI’s quiet earnings role, and more 20.10.2026 54:36
Earnings season is here, and Kevin and Martin preview what they’re listening for in Q3, starting with government programs. They discuss Medicare Advantage plans pruning PPOs in favor of C-SNPs and D-SNPs, the growth outlook for Humana and Alignment, and Clover’s five-star rating heading into AEP. On Medicaid, they cover plans’ view that 2026 is the trough and early disenrollment data from Nebraska...
The Grand Roundup: 2027 Stars winners and losers, Atrium vs. NC State Health Plan, No Surprises Act fix, Megan Fox and D2C consumerism, and more 12.10.2026 1:17:42
Kevin and Martin start with a discussion of the 2027 Stars ratings. The big takeaway: the results were good enough for most plans that Congress won’t feel pressure to fix the program. From there, they cover the fight between Atrium and the NC State Health Plan. That leads into Frank Pallone’s bill to replace No Surprises Act arbitration with an inflation-adjusted QPA, and the real question underne...
The Grand Roundup: Devoted's $25B round, Oura's IPO, Cigna Investor Day, the C-SNP gold rush, and more 06.10.2026 1:03:44
Kevin and Martin spend the first half of this week's episode on Devoted Health, which formally announced a $1.18B Series G at a $25B valuation. They get into the NAIC filings showing a 1.1% margin, confirmation that Devoted is profitable at the parent level, the 13 Series F investors who sat this round out, and why 133 new C-SNP plans in the MA landscape file might be the real story. Is the AI-dri...
The Grand Roundup: AI agents turn insurance friction into a cost center, Rightway and transparent PBMs, longevity goes to work, Cigna investor day, and more 29.09.2026 46:54
Kevin and Martin kick off with the latest Citrini report and its argument that AI agents will turn friction from a profit center into a cost center, with health insurance as exhibit A. Martin doesn't buy the idea that payers unwind, but thinks bots that fight every denial and prior auth mean higher premiums down the road. Kevin brings in the NYT story on SmarterDx and McLaren to ask whether all th...
The Grand Roundup: Oscar's Investor Day, Alignment Health's mysterious 35% drop, OpenEvidence's oncology pivot, Walmart's GLP-1 pharmacist pilot, and more 21.09.2026 1:00:31
Kevin and Martin open with a wild AI story: a personal-assistant app is now negotiating discounts with telehealth vendors on users' behalf, opening up some genuinely strange territory around bots negotiating with other bots. From there it's Oscar's Investor Day: Bertolini's pitch that the individual market is a $350 billion opportunity, the ICHRA/Choice and Lucie marketplace ambitions, and whether...
The Grand Roundup: Autonomous clinical AI is here, challenger health plans vs. the incumbents, InnovAge's PACE push, a private markets roundup, and more 14.09.2026 57:35
Kevin and Martin open on where autonomous clinical AI actually stands post-ARPA-H awards and the Zeke Emanuel conversation. They then discuss whether employer-sponsored insurance is nearing its end — Julie Yoo’s "Great Health Plan Replacement" thesis, Surest, and the CrowdHealth risk-pool debate Next, they dig into Omada's inaugural investor day: the PBM-as-channel go-to-market strategy and update...
The Grand Roundup: Wildflower Health CEO Leah Sparks on the $100B maternal health gap, the Every Mother acquisition, and D2C's next frontier 31.08.2026 47:32
This week's Grand Roundup is a replay of last week's Health Tech Nerds company presentation: Kevin sits down with Leah Sparks, CEO and founder of Wildflower Health, for a look into the maternal health and women's health market. Leah walks through Wildflower's model — a digital and AI-enabled wraparound care layer that fills the gaps between OB visits for pregnant and postpartum patients, working a...
The Grand Roundup: Q2 earnings special — AI ROI finally shows up, managed care's comeback, Molina's ACA spiral, Hims' Bluetooth pill box pitch, and more 24.08.2026 59:07
Kevin and Martin are out this week, so TGR is running our Q2 earnings wrap-up with HTN's Sean Leimbach, covering the quarter across the HTN Research coverage universe. First up: AI. Centene's Sarah London gave what Kevin calls “the quote of earnings season” on the risk of spending big with no return, while Astrana pointed to a 210 basis point G&A win and Doximity's stock jumped 30%. From there...
The Grand Roundup: Medicare for All's trillion-dollar trade-offs, STAT’s Commure probe, the ICHRA covered-lives boom, new rounds for Aligned Marketplace and Innovaccer, and more 17.08.2026 1:02:47
Kevin and Martin open on employer health: Bloomberg is asking staff to contribute to health insurance premiums after years of covering 100%, and a new survey shows small employers fleeing the big-three PBMs for centers of excellence and advanced primary care. Then they discuss Aligned Marketplace's $20 million raise and an HRA Council survey showing ICHRA lives roughly doubled year over year. They...
The Grand Roundup: Doximity's AI comeback, Bank of America's $250M GLP-1 bet, Clover and Oscar's blowout quarters, HCMC's $705M bailout, and more 10.08.2026 1:00:05
Kevin and Martin dig into a busy week of Q2 earnings, starting with Doximity's whiplash quarter. From there they run through then payer calls: Oscar and Clover both grew close to 50% while improving MLR. They discuss Oscar's Oswell radiology agent and Clover's Counterpart licensing play, Hinge Health's investor day excitement and Cylinder acquisition, and Bank of America's $250 million GLP-1 spend...
The Grand Roundup: BetterHelp’s cash pay collapse, Centene-Molina ACA divergence, Function’s 450M debt raise, Iowa’s managed care debate, and more 03.08.2026 1:00:44
Kevin and Martin chat about a packed earnings week: Teladoc's BetterHelp cash pay business fell off a cliff in mid-May, Humana passed its 2026 MA stress test but is still terming 600,000 members from low-star plans to hit its 2028 margin target, Centene raised ACA guidance a week after Molina's "death spiral" quarter, and Centene’s Sarah London's blunt AI cost-management comments drew comparisons...
The Grand Roundup: Payer Q2 earnings, HCA's ACA miss, OpenEvidence & Doximity's PR war, fee schedule backlash, Neko's $7B valuation, and more 20.07.2026 1:02:43
Kevin and Martin kick off with Q2 payer earnings. Elevance's stock fell 11% despite beating estimates because the company signaled Medicaid market exits without giving Wall Street any sizing to work with, while United warned that the No Surprises Act is driving commercial trend higher than expected. They then discuss the OpenEvidence-Doximity documentation fight, with both citing the same study as...
Betting on regulatory tailwinds: how Evidenced picks its deals | Bryan Sivak & Sean Glass 16.07.2026 22:17
Bryan Sivak and Sean Glass closed a $24 million first fund for Evidenced. They invest in healthcare companies benefiting from a regulatory or policy tailwind that pushes buyers to act sooner or spend more. Both are repeat entrepreneurs — Sivak sold his company, Glass took his public — and they walk through the portfolio bets that prove the thesis out, from a community health worker platform spun o...
CMS Bridge forecast, broker fraud, and the ACA numbers everyone's misreading | Sam Melamed (NCD) 15.07.2026 24:01
Sam Melamed spent 20 years building Insurance Forums into the largest online community for insurance agents and brokers before becoming CEO of NCD, a top-rated dental, vision, and supplemental benefits administrator, five years ago. He argues fears of an ACA "death spiral" are overstated, and pushes back on claims that fraud alone explains recent enrollment declines. He also breaks down how CMS's...
The Grand Roundup: Debating the future of ESI, concierge medicine's $40K price tag, Elevance/SCAN sue over Stars, ACA rate hikes and death spiral fears, and more 13.07.2026 1:25:30
Kevin and Martin open by discussing a question that recently surfaced in the Health Tech Nerds Slack community: is employer-sponsored insurance actually crumbling, or just showing its age? They then move into a conversation about Midi's CEO calling out a $40K/year concierge menopause practice on LinkedIn and a run of quick hits: Elevance and SCAN joining Clover in suing over Stars ratings, a Wall...
A physician-turned-founder's take on making prior auth actually work | Jeremy Friese (Humata Health) 01.07.2026 17:38
Jeremy Friese spent a decade as a physician at Mayo Clinic navigating prior auth from the provider side. Now he runs Humata Health, which helps large health systems submit better prior auths to every plan in the country. Humata is a participant in CMMI's WISeR program, handling Oklahoma's fee-for-service Medicare prior auth, and six months in, providers are submitting almost exclusively through Hu...
The Grand Roundup: Agentic voice AI wars, recent funding roundup, Cityblock acquires Homeward, UpDoc's FDA clearance, Humata's WISeR rollout, and more 29.06.2026 1:20:00
Kevin and Martin start with a discussion about a crowded week in healthcare AI funding. Prosper AI and Assort Health’s fundraising announcements were released on back-to-back days, with nearly identical customer quotes claiming each was "the only true platform." Kevin and Martin work through what that signals about the agentic voice AI space. They also cover Alan's €480M raise at a $6.3B valuation...
The liability gap holding clinical AI back — and who should solve it | JD Friedland (Cleveland Clinic) 25.06.2026 18:57
JD Friedland is the executive director for ventures at Cleveland Clinic, where he evaluates and deploys emerging health technology across one of the country's largest and most research-intensive health systems. He walks through what Cleveland Clinic has actually built — some examples include: sepsis detection with Bayesian, clinical trial recruitment via Dyania, and surgical note generation throug...
The Grand Roundup: Anti-tiering contracts and the OhioHealth ruling, Thoreau/Ensemble update, 340B and Eli Lilly, OpenLoop's D2C play, Cleveland Clinic on AI trust, and more 22.06.2026 1:20:59
Kevin and Martin by discussing the OhioHealth DOJ settlement and what banning anti-tiering, anti-steering clauses in hospital contracts could mean for employer plan design, narrow networks, and upstart insurance models. They talk about the $12B Ensemble Health Partners deal: what it says about the RCM market's appetite for holistic versus point-solution approaches, and where it might fit into Matt...
The tasks AI should take off doctors' plates — and the ones it shouldn't | Hashem Zikry (Counsel Health) 17.06.2026 15:49
Hashem Zikry is a practicing emergency physician at UCLA, a researcher focused on unnecessary ED utilization, and the medical director for clinical research and policy at Counsel Health — which, this week, began integrating Oura biometric data into clinical decision-making for the first time. That combination of roles gives him an unusual perspective on the question everyone is asking: what should...
How Alignment Health gets health systems to come to them | John Kao (Alignment Health) 16.06.2026 19:48
Thirty-five years into Medicare Advantage, John Kao sees the V28 correction as a pricing reset, not a structural rupture. Plans that invested in clinical care delivery are emerging from it better positioned than those that leaned on coding and prior auth. He expects MA to capture 65–70% of the senior market within the next decade — and argues the current administration's push on program integrity...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.